Th1 (IL-2, interferon-gamma (IFN-γ)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)

Clinical and Experimental Immunology

Volumn 115, Issue 1, 1999, Pages 189-195

  Viallard, Jean Francois ^a,b   Pellegrin, J L ^a   Ranchin, V ^c   Schaeverbeke, T ^d   Dehais, J ^d   Longy Boursier, M ^e   Ragnaud, J M ^d   Leng, B ^a   Moreau, J F ^b  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b CNRS Bordeaux Segalen University   (France)

^c Immunotech   (France)

^d HÔPITAL PELLEGRIN   (France)

^e HÔPITAL SAINT ANDRÉ   (France)

Author keywords

IL 10; IL 2; IL 4; Interferon gamma; Systemic lupus erythematosus

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS;

EID: 0032939098     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00766.x     Document Type: Article

References (47)

1. 1 Klinman DM, Steinberg AD. Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 1987; 165:1755-60.
2. 2 Cherwinski HM, Schumacher JH, Brown KD, Mosmann TR. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med 1987; 166:1229-44.
3. 3 Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-73.
4. + T cells and their role in the induction and prevention of autoimmunity. Immunol Rev 1991; 123:37-64.
5. 5 Romagnani S. Human TH1 and TH2 subsets: doubt no more. Immunol Today 1991; 12:256-7.
6. 6 Romagnani S. Lymphokine production by human T cells in disease states. Annui Rev Immunol 1994; 12:227-57.
7. 7 Snapper CM, Mond JJ. Towards a comprehensive view of immunoglobulin class switching. Immunol Today 1993; 14:15-17.
8. 8 Goldman M, Druet P, Gleichmann E. Th2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 1991; 12:223-7.
9. 1 lupus-like nephritis with monoclonal antibody to γ interferon. J Exp Med 1987; 166:798-803.
10. 10 De Groote D, Zangerle PF, Gevaert Y et al. Direct stimulation of cytokines (IL-1 beta; TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. Comparison with isolated PBMC stimulation. Cytokine 1992; 4:239-48.
11. 11 Zangerle PF, De Groote D, Lopez M et al. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine 1992; 4:568-75.
12. 12 Chernoff AE, Granowitz EV, Shapiro L et al. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 1995; 154:5492-9.
13. 13 Petrovsky N, Harrison LC. Cytokine-based human whole blood assay for the detection of antigen-reactive T cells. J Immunol Methods 1995; 186:37-46.
14. 14 Johnson K, Aarden L, Choi Y, De Groot F, Creasey A. The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996; 87:5051-60.
15. 15 Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythemalosus. Arthritis Rheum 1982; 25:1271-7.
16. 16 Asherson RA. A 'primary' antiphospholipid syndrome? J Rheumatol 1988; 15:1742-6.
17. 17 Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32:1107-18.
18. 18 O'Brien PC, Shampo MA, Dyck PJ. Statistical analysis in clinical laboratory medicine: fundamentals and common uses. Crit Rev Lab Sci 1989; 27:319-40.
19. 19 Swaak AJG, van den Brink HG, Aarden LA. Cytokine production (IL-6 and TNFα) in whole blood cell cultures of patients with systemic lupus erythematosus. Scand J Rheumatol 1996; 25:233-8.
20. 20 Kallmann BA, Hauler M, Tubes M, Feldkamp J, Bertrams J, Gries FA, Lampeter EF, Kolb H. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Grave's disease. Diabetes 1997; 46:237-43.
21. 21 Llorente L, Richaud-Patin Y, Wijdenes J et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993; 4:421-7.
22. 22 Llorente L, Zou W, Levy Y et al. Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181:839-44.
23. 23 Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Morel Fourrier B, Galanaud P, Emilie D. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. Arthritis Rheum 1994; 37:1647-55.
24. 24 Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mossman TR. Interleukin-10. Annu Rev Immunol 1993; 11:165-90.
25. 25 Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mossman TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990; 248:1230-4.
26. 26 Fiorentino DF, Zlotnik A, Mossman TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 146:3815-22.
27. 27 Fiorentine DF, Zlotnik A, Vieira P, Mossman TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cells to inhibit cytokine production by Th1 cells. J Immunol 1991; 146:3444-51.
28. 28 Rennick D, Berg D, Holland G. Interleukin-10: an overview. Prog Growth Factor Res 1992; 4:207-27.
29. 29 Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151:1224-34.
30. 30 Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol 1992; 148:1792-6.
31. 31 Roussel F, Garcia E, Defrance T, Peronne C, Hsu DH, Kastelein R, Moore KW, Banchereau J. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89:1890-3.
32. 32 Takahashi S, Fossati L, Iwamoto M, Mérino R, Motta R, Kobayakawa T, Izui S. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 1996; 97:1597-604.
33. 33 Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13:58-67.
34. 34 Tsokos GC, Boumpas DT, Smith PL. Deficient gamma-interferon production in patients with systemic lupus erythematosus. Arthritis Rheum 1986; 29:1210-5.
35. 35 Alcocer-Varela J, Alarcon-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 1982; 69:1388-92.
36. 36 Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA. Defective production of interleukin-1 and interleukin-2 in patients with systemic lupus erythematosus. J Immunol 1983; 130:2651-5.
37. 37 de Faucal P, Godard A, Peyrat MA, Moreau JF, Soulillou JP. Impaired IL2 production by lymphocytes of patients with systemic lupus erythematosus. Ann Immunol (Inst Pasteur) 1984; 135D:161-72.
38. 38 Draeger AM, Swaak AJ, van der Brink HG, Aarden LA. T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin-2. Clin Exp Immunol 1986; 64:80-87.
39. 39 Kaplan D. Autocrine secretion and the physiological concentration of cytokines. Immunol Today 1996; 17:303-4.
40. 40 Hallet MM, Peyrat MA, Moisan JP, Soulillou JP, Moreau JF. Proliferation dependence and production of IL-2 in human alloreactive T-cell clones. Cell Immunol 1989; 124:95-106.
41. 41 Claret E, Renversez JC, Zheng X, Bonnefoix T, Sotto JJ. Valid estimation of IL-2 secretion by PHA-stimulated T-cell clones absolutely requires the use of anti-CD25 monoclonal antibody to prevent IL-2 consumption. Immunol Letters 1992; 33:179-86.
42. 42 Seder RA, Le Gros G, Ben-Sasson SZ, Urban J Jr, Finkelman FD, Paul WE. Increased frequency of IL-4 producing T cells as a result of polyclonal priming. Use of a single-cell assay to detect IL-4 producing cells. Eur J Immunol 1991; 21:1241-7.
43. 43 Erb KJ, Ruger B, von Brevern M, Ryffel B, Schimpl A, Rivett K. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med 1997; 185:329-39.
44. 44 Santiago ML, Fossati L, Jacquet C, Müller W, Izui S, Reininger L. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 1997; 185:65-70.
45. + T cells in a Th2 response and in immunoglobulin E production. Science 1995; 270:1845-7.
46. 46 Davodeau F, Peyrat MA, Necker A et al. Close phenotypic and functional similarities between human and murine αβ T cells expressing invariant TCR α-chains. J Immunol 1997; 58:5603-11.
47. 47 Hagiwara E, Gourley MF, Lee S, Klinman DM. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum 1996; 39:379-85.